Skip to content

Medical-device intelligence

MID: System, Test, Anticardiolipin Immunological

FDA product code MID: System, Test, Anticardiolipin Immunological. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MID
FDA device name
System, Test, Anticardiolipin Immunological
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

94 clearance records and 17 recall records in the covered releases, across 38 source company names and 1 product codes. Dated history runs from Nov 19, 1991 to Dec 17, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MID · System, Test, Anticardiolipin Immunological9417

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

111 matching records
Device / recordCompany in FDA recordSourceSource date
AESKULISA CARDIOLIPIN AGMK040463 · MIDAesku, Inc.510(k)May 12, 2004FDA decision date
REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139K032868 · MIDCorgenix, Inc.510(k)Oct 14, 2003FDA decision date
BINDAZYME HUMAN ANTI-PHOSPHATIDYLSERINE IGA, IGG AND IGM ENZYME IMMUNOASSAY KITK032240 · MIDThe Binding Site, Ltd.510(k)Sep 29, 2003FDA decision date
Anti-Cardiolipin IgA ELISA test kit. Product is manufactured by Zeus Scientific, Branchburg, NJ for Sigma Diagnostics, Inc., Saint Louis, MO.Z-1147-03 · MIDZeus Scientific IncRecallAug 21, 2003FDA classification date
Bindazyme, Human AntiCardiolipin IgM Enzyme Immunoassay Kits, MK029Z-0950-03 · MIDBinding Site Inc TheRecallJun 21, 2003FDA classification date
AUTOSTAT II ANTI-CARDIOLIPIN IGA ELISAK030741 · MIDHycor Biomedical , Ltd.510(k)May 1, 2003FDA decision date
MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KITK024195 · MIDCorgenix, Inc.510(k)Jan 3, 2003FDA decision date
REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK024196 · MIDCorgenix, Inc.510(k)Jan 3, 2003FDA decision date
VARELISA CARDIOLIPIN ANTIBODIES SCREEN, MODELS 15848 AND 15896K023433 · MIDPharmacia Diagnostics GmbH & Co. KG510(k)Nov 13, 2002FDA decision date
REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001K022990 · MIDCorgenix, Inc.510(k)Sep 25, 2002FDA decision date
REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001K022992 · MIDCorgenix, Inc.510(k)Sep 25, 2002FDA decision date
APL IGA ELISA KITK021398 · MIDLouisville Apl Diagnostics, Inc.510(k)Aug 27, 2002FDA decision date
QACA IGG/IGM ELISA KIT HRPK021192 · MIDCheshire Diagnostics , Ltd.510(k)May 16, 2002FDA decision date
VARELISA CARDIOLIPIN IGG ANTIBODIES, MODELS 15548 & 15596K020752 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date
VARELISA CARDIOLIPIN IGA ANTIBODIES, MODELS 15748 & 15796K020757 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date
VARELISA CARDIOLIPIN IGM ANTIBODIES, MODELS 15648 & 15696K020758 · MIDPharmacia Deutschland GmbH510(k)May 2, 2002FDA decision date
QACA IGG/IGM ELISA KITK020241 · MIDCheshire Diagnostics , Ltd.510(k)Mar 13, 2002FDA decision date
DIASTAT TOTAL ANTI-CARDIOLIPIN, MODEL FCAR 100TK020156 · MIDAxis-Shield Diagnostics, Ltd.510(k)Mar 6, 2002FDA decision date
DIAMEDIX IS-ANTI-CARDIOLIPIN IGG/IGM TEST SYSTEMK012449 · MIDDiamedix Corp.510(k)Oct 26, 2001FDA decision date
DIAMEDIX IS-ANTI-CARDIOLIPIN IGA TEST SYSTEMK012450 · MIDDiamedix Corp.510(k)Oct 26, 2001FDA decision date
REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTITIVE TEST KITK013018 · MIDCorgenix, Inc.510(k)Sep 20, 2001FDA decision date
MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK012567 · MIDCorgenix, Inc.510(k)Aug 23, 2001FDA decision date
DIAMEDIX IS-ANTI-CARDIOLIPIN SCREEN TEST SYSTEMK012053 · MIDDiamedix Corp.510(k)Aug 20, 2001FDA decision date
ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEMK003069 · MIDQuest Intl., Inc.510(k)Nov 27, 2000FDA decision date
DIASTAT ANTI-CARDIOLIPIN IGA, MODEL FCAR 500K001981 · MIDAxis-Shield , Ltd.510(k)Aug 21, 2000FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗